Ockham's Razor and Selective Androgen Receptor Modulators (SARMs): Are We Overlooking the Role of 5 -Reductase?
Open Access
- 1 February 2007
- journal article
- review article
- Published by CLOCKSS Archive in Molecular Interventions
- Vol. 7 (1) , 10-13
- https://doi.org/10.1124/mi.7.1.3
Abstract
Selective Androgen Receptor Modulators (SARMs) are a novel class of AR ligands that possess tissue-selective pharmacological activities. SARMs of various chemical structures have been discovered and characterized, and lead compounds with much improved specificity for AR, in vivo pharmacokinetic profiles, and higher degree of tissue selectivity have entered clinical development, and are expected to dramatically expand the clinical applications of androgens. With the rapid progress in SARM discovery and increasing demand for mechanism-based drug design, more and more research efforts have been devoted to the mechanisms of action of the observed tissue selectivity of SARMs. There is increasing enthusiasm in adapting the molecular mechanisms of action from SERM research to the SARM field; however, is the SARM story really so complicated? The tissue-specific expression of 5alpha-reductase might provide a simple explanation for this puzzle.Keywords
This publication has 22 references indexed in Scilit:
- Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamideNuclear Medicine and Biology, 2006
- Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor LigandsPharmaceutical Research, 2006
- Linking Ligand-Induced Alterations in Androgen Receptor Structure to Differential Gene Expression: A First Step in the Rational Design of Selective Androgen Receptor ModulatorsMolecular Endocrinology, 2006
- Structural Basis for Accommodation of Nonsteroidal Ligands in the Androgen ReceptorJournal of Biological Chemistry, 2005
- Chemistry and Structural Biology of Androgen ReceptorChemical Reviews, 2005
- Discovery and Therapeutic Promise of Selective Androgen Receptor ModulatorsMolecular Interventions, 2005
- Structural Basis for an Unexpected Mode of SERM-Mediated ER AntagonismMolecular Cell, 2005
- Pharmacodynamics of Selective Androgen Receptor ModulatorsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Discovery of Nonsteroidal AndrogensBiochemical and Biophysical Research Communications, 1998
- Design of Antiandrogens and Their Mechanisms of Action: A Case Study (Anandron)Hormone Research, 1987